1. Home
  2. VSTS vs SUPN Comparison

VSTS vs SUPN Comparison

Compare VSTS & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$7.51

Market Cap

572.2M

Sector

N/A

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.49

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
SUPN
Founded
1936
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
572.2M
2.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
VSTS
SUPN
Price
$7.51
$47.49
Analyst Decision
Sell
Strong Buy
Analyst Count
4
4
Target Price
$5.95
$63.25
AVG Volume (30 Days)
3.2M
664.8K
Earning Date
01-30-2026
11-04-2025
Dividend Yield
0.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,734,839,000.00
$681,539,000.00
Revenue This Year
$1.47
$8.32
Revenue Next Year
$3.06
$23.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.54
52 Week Low
$3.98
$29.16
52 Week High
$16.68
$57.65

Technical Indicators

Market Signals
Indicator
VSTS
SUPN
Relative Strength Index (RSI) 73.10 54.34
Support Level $7.10 $45.36
Resistance Level $7.71 $47.26
Average True Range (ATR) 0.41 1.23
MACD 0.08 0.40
Stochastic Oscillator 91.29 91.91

Price Performance

Historical Comparison
VSTS
SUPN

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: